Brief: Akoya Biosciences Inc Reports Fourth Quarter And Full Year 2021 Operating Results
14/03/2022 20:07
March 14 (Reuters) - Akoya Biosciences Inc AKYA.O :
* AKOYA REPORTS FOURTH QUARTER AND FULL YEAR 2021 OPERATING
RESULTS AND PROVIDES 2022 FINANCIAL OUTLOOK
* SEES FY REVENUE $69 MILLION TO $71 MILLION
* Q4 REVENUE ROSE 26 PERCENT TO $16.2 MILLION
Source text for Eikon: ID:nGNXbLrKMT
Further company coverage: AKYA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks